vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
Crexendo, Inc. is the larger business by last-quarter revenue ($18.1M vs $13.2M, roughly 1.4× TriSalus Life Sciences, Inc.). Crexendo, Inc. runs the higher net margin — 6.7% vs -73.9%, a 80.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 11.2%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 12.4%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
CXDO vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $13.2M |
| Net Profit | $1.2M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 6.3% | -24.8% |
| Net Margin | 6.7% | -73.9% |
| Revenue YoY | 11.2% | 59.8% |
| Net Profit YoY | 140.2% | 3.5% |
| EPS (diluted) | $0.03 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $13.2M | ||
| Q3 25 | $17.5M | $11.6M | ||
| Q2 25 | $16.6M | $11.2M | ||
| Q1 25 | $16.1M | $9.2M | ||
| Q4 24 | $16.2M | $8.3M | ||
| Q3 24 | $15.6M | $7.3M | ||
| Q2 24 | $14.7M | $7.4M | ||
| Q1 24 | $14.3M | $6.5M |
| Q4 25 | $1.2M | $-9.8M | ||
| Q3 25 | $1.4M | $-10.8M | ||
| Q2 25 | $1.2M | $-8.3M | ||
| Q1 25 | $1.2M | $-10.4M | ||
| Q4 24 | $507.0K | $-10.1M | ||
| Q3 24 | $148.0K | $-2.4M | ||
| Q2 24 | $588.0K | $-4.3M | ||
| Q1 24 | $434.0K | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 6.3% | -24.8% | ||
| Q3 25 | 7.5% | -77.9% | ||
| Q2 25 | 6.7% | -65.4% | ||
| Q1 25 | 7.2% | -79.9% | ||
| Q4 24 | 3.9% | -91.8% | ||
| Q3 24 | 0.9% | -118.9% | ||
| Q2 24 | 3.9% | -111.0% | ||
| Q1 24 | 3.4% | -180.8% |
| Q4 25 | 6.7% | -73.9% | ||
| Q3 25 | 8.3% | -93.5% | ||
| Q2 25 | 7.4% | -73.9% | ||
| Q1 25 | 7.3% | -113.2% | ||
| Q4 24 | 3.1% | -122.4% | ||
| Q3 24 | 0.9% | -32.6% | ||
| Q2 24 | 4.0% | -58.8% | ||
| Q1 24 | 3.0% | -204.5% |
| Q4 25 | $0.03 | $-0.22 | ||
| Q3 25 | $0.05 | $-0.96 | ||
| Q2 25 | $0.04 | $-0.27 | ||
| Q1 25 | $0.04 | $-0.39 | ||
| Q4 24 | $0.03 | $-0.38 | ||
| Q3 24 | $0.00 | $-0.12 | ||
| Q2 24 | $0.02 | $-0.21 | ||
| Q1 24 | $0.01 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $-33.9M |
| Total Assets | $77.7M | $35.3M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | — | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $-33.9M | ||
| Q3 25 | $61.3M | $-26.7M | ||
| Q2 25 | $58.3M | $-19.4M | ||
| Q1 25 | $55.2M | $-34.4M | ||
| Q4 24 | $51.4M | $-25.9M | ||
| Q3 24 | $49.5M | $-20.4M | ||
| Q2 24 | $48.2M | $-25.3M | ||
| Q1 24 | $46.8M | $-36.0M |
| Q4 25 | $77.7M | $35.3M | ||
| Q3 25 | $76.0M | $36.5M | ||
| Q2 25 | $71.4M | $41.3M | ||
| Q1 25 | $67.4M | $28.6M | ||
| Q4 24 | $64.9M | $24.0M | ||
| Q3 24 | $62.3M | $27.5M | ||
| Q2 24 | $59.6M | $32.4M | ||
| Q1 24 | $57.5M | $17.9M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-2.5M | ||
| Q3 25 | $4.4M | $-3.7M | ||
| Q2 25 | $1.3M | $-7.3M | ||
| Q1 25 | $1.2M | $-4.5M | ||
| Q4 24 | $2.2M | $-5.7M | ||
| Q3 24 | $1.6M | $-10.8M | ||
| Q2 24 | $2.7M | $-13.4M | ||
| Q1 24 | $-166.0K | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | $1.3M | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | $2.1M | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | 7.7% | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | 13.2% | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 0.1% | 0.8% | ||
| Q1 25 | 0.0% | 8.2% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.0% | 1.0% |
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | 10.95× | — | ||
| Q2 24 | 4.51× | — | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
TLSI
Segment breakdown not available.
